+499.5%
MRNA vs GTLB
+14.4%
+485.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GTLB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.1% | -3.3% | -2.4% |
| 7D | +5.5% | +11.1% | -5.6% | +3.1% |
| 30D | +158.7% | +37.8% | +120.9% | +145.8% |
| 3M | +182.1% | +61.6% | +120.6% | +164.7% |
| 6M | +151.8% | +98.9% | +52.9% | +133.1% |
| YTD | +393.6% | +32.8% | +360.8% | +371.7% |
| 1Y | +499.5% | +14.7% | +484.8% | +494.1% |
| All | +499.5% | +14.4% | +485.0% | +494.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GTLB.
Daily Out/Under-Performance
Portfolio return minus GTLB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GTLB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GTLB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling